Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility Study of a Novel Neurofeedback Technology (GZNT) for Persistent Post-Concussive Symptoms in Soldiers

NCT02509689 is registered in ClinicalTrials.gov with The Defense and Veterans Brain Injury Center as lead sponsor.

NCT NCT02509689
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02509689 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility Study of a Novel Neurofeedback Technology (GZNT) for Persistent Post-Concussive Symptoms in Soldiers
Lead sponsor
The Defense and Veterans Brain Injury Center
Phase
Not applicable
Overall status
Completed
Start date
December 31, 2014
Completion date
March 31, 2022
Enrollment
172 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

traumatic brain injury